Shaista Husain in Houston, Texas

Home Texas Houston

Shaista Husain has Otolaryngology as her primary medical specialty. Their primary office is: 10021 Main St in Houston, Texas. They attended Sorry, her university is not listed and graduated in 1975 (around 49 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Shaista Husain Office Phone and Directions

Shaista Husain
10021 Main St
Houston, Texas 77025
832-366-1477

Patient Ratings
Please rate your experience with Shaista Husain below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 832-366-1477

Enter a starting address:

Healthcare Info for Shaista Husain

Additional Medical Specialties Include:
ALLERGY/IMMUNOLOGY

Medical School: Sorry, her university is not listed
Graduation Year: 1975
The Primary Medical Specialty for Shaista Husain is listed as: Otolaryngology
Approximate Years of Experience: 49
PAC (PECOS ID)#: 6406834514
NPI #: 1700812179
NPI Created On: 06/25/2006
NPI Last Updated Listed as: 03/09/2021
Primary Taxonomy Code: 207Y00000X
License Number:
J0534
Listed Gender: Female

Accepted forms of Insurance

Forms of insurance accepted by include, but are not limited to:

Humana
Community Health Choice
Molina Marketplace
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Urdu, Spanish, Hindi.

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 851668711

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Otolaryngology (Ear, Nose, Throat)

Name of Drug #1: Xhance

Open Associated Drug #1: 71143-375-01